Evidence map›Paper›PMID 36680003›Full record

ArticleVaccines2023

Central and Effector Memory Human CD4+ and CD8+ T Cells during Cutaneous Leishmaniasis and after In Vitro Stimulation with Leishmania (Viannia) braziliensis Epitopes

Beatriz Coutinho de Oliveira, Ailton Alvaro da Silva, Marton Kaique de Andrade Cavalcante, Maria Edileuza Felinto de Brito, Maria Carolina Accioly Brelaz de Castro, Vanessa Lucília Silveira de Medeiros, Rafael de Freitas E Silva, Valéria Rêgo Alves Pereira

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Vaccines, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Human T-cell activation withLife science alliance · 2024
    Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Beatriz Coutinho de OliveiraCleveland Clinic Lerner College of Medicine, Cleveland, OH 44195, USA.
Ailton Alvaro da SilvaTherapeutic Innovation Graduate Program (PPGIT), Federal University of Pernambuco, Recife 50670-901, Brazil.
Marton Kaique de Andrade CavalcanteTherapeutic Innovation Graduate Program (PPGIT), Federal University of Pernambuco, Recife 50670-901, Brazil.ORCID 0000-0001-9995-7352
Maria Edileuza Felinto de BritoImmunology Department, Aggeu Magalhães Institute, Recife 50740-465, Brazil.
Maria Carolina Accioly Brelaz de CastroTherapeutic Innovation Graduate Program (PPGIT), Federal University of Pernambuco, Recife 50670-901, Brazil.
Vanessa Lucília Silveira de MedeirosDermatology Clinics, Tropical Medicine Department, Clinics Hospital, Federal University of Pernambuco, Recife 50670-901, Brazil.
Rafael de Freitas E SilvaDepartment of Natural Sciences, University of Pernambuco, Garanhuns Campus, Garanhuns 55294-902, Brazil.
Valéria Rêgo Alves PereiraTherapeutic Innovation Graduate Program (PPGIT), Federal University of Pernambuco, Recife 50670-901, Brazil.
Universidade Federal de Pernambuco · BRUniversidade de Pernambuco · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cutaneous Leishmaniasis (CL) is a Neglected Tropical Disease characterized by skin ulcers caused by

Indexed as

Cutaneous LeishmaniasisLeishmania (Viannia) braziliensismemory T cellspeptidesvaccine

Identifiers

PMID36680003
PMCPMC9861845
OpenAlexW4315647280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.